Kidney injury molecule-1 and cystatin C as early biomarkers for renal dysfunction in Iraqi type 2 diabetes mellitus patients
Journal of Advanced Biotechnology and Experimental Therapeutics, ISSN: 2616-4760, Vol: 6, Issue: 3, Page: 673-685
2023
- 1Citations
- 7Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Diabetic kidney disease (DKD) is caused by a variety of processes. As a result, one biomarker is insufficient to represent the complete process. This study evaluated the diagnostic value of serum kidney injury molecule-1(KIM-1) and cystatin C (CysC) as early biochemical markers ICLE of DKD and predicted their sensitivities and specificities as biomarkers of nephropathy in Iraqi type 2 diabetic (T2DM) patients. This cross-sectional study includes 161 T2DM patients. Patients were divided according to urinary albumin creatinine ratio (ACR) such as group1: ACR≤ 30mg/g and group2: ACR> 30mg/g. Random spot urine and fasting blood samples were taken from each patient. Urinary ACR, blood glycated hemoglobin (HbA1c), and serum glucose, creatinine (SCr), lipid profile, CysC, and KIM-1 were assayed, and the estimated glomerular filtration rat (eGFR) was calculated. When compared to the normoalbuminuric group, the DKD group had significantly greater prevalence of retinopathy, and significantly elevated HbA1c and total cholesterol values. Also, DKD group had significantly greater serum levels of KIM-1 and CysC, and there was a significant positive correlation between them. In contrast, GFR was significantly higher in normoalbuminuric group and was significantly negatively correlated with both CysC and KIM-1. Multiple linear regression analysis found that there were a significant positive association among CysC and ACR. Receiver operating characteristic (ROC) analysis revealed that eGFR had the highest area under the curve (AUC=0.717), while SCr had the lowest AUC (0.556). In conclusion, serum KIM-1 and CysC levels could be considered as early biomarker for DKD along with eGFR. Additionally, there was a strong correlation between serum CysC and KIM-1 as well as other renal measures that indicate deteriorating kidney function.
Bibliographic Details
ScopeMed
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know